An Overview of Electrical Nerve Stimulation via Transdermal Application

Yashodhar Reddy Srungarapu

doi:10.37022/jpmhs.v7i2.110

Authors

Srungarapu Yashodhar Reddy Priyadarshini Institute of Pharmaceutical Education and Research, 5th Mile, Pulladigunta, Guntur-522017.Andhra Pradesh, India.

DOI:

https://doi.org/10.37022/jpmhs.v7i2.110

Keywords:

Resistant hypertension [RH], Blood pressure [BP], Chronic primary low back pain [CPLBP], Transcutaneous electrical nerve stimulations [TENS]

Abstract

The risk of dying from cardiovascular and cerebrovascular diseases is significantly increased by hypertension. The primary issues affecting public health at the moment are hypertension and its consequences. Some persons with hypertension, even under intensive therapeutic supervision, do not achieve the specified blood pressure (BP) treatment targets. Patients with resistant hypertension (RH) may be defined as those who need to take three or more different kinds of antihypertensive medications in order to reach their blood pressure target. Utilizing the body's natural bioelectric system, bioelectric technology is a relatively new approach. In auxiliary evaluation, pain management, and organ function rehabilitation, it is commonly used. Renal sympathetic denervation, carotid baroreflex activation therapy, electroacupuncture in traditional Chinese medicine, and transcutaneous electrical nerve stimulation are the primary forms of bioelectrical technology, which has advanced quickly in recent years as an effective treatment for RH.

Downloads

Download data is not yet available.

References

BMJ 2012; 345 doi: (Published 20 November 2012)Cite this as: BMJ 2012;345:e7473 https://doi.org/10.1136/bmj.e7473

Rimoldi SF, Messerli FH, Bangalore S, Scherrer U. Resistant hypertension: what the cardiologist needs to know. European heart journal. 2015 Oct 21;36(40):2686-95.

https://academic.oup.com/eurheartj/article/36/40/2686/2293386

Achelrod D, Wenzel U, Frey S. Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations. American journal of hypertension. 2015 Mar 1;28(3):355-61

https://academic.oup.com/ajh/article/28/3/355/2743335

de Jager RL, Blankestijn PJ. Pathophysiology I: the kidney and the sympathetic nervous system. Eurointervention: Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2013 May 1;9:R42-7.

https://europepmc.org/article/med/23732154

Wang C, Wang P, Qi G. A new use of transcutaneous electrical nerve stimulation: Role of bioelectric technology in resistant hypertension (Review). Biomed Rep. 2023 Apr 18;18(6):38. doi: 10.3892/br.2023.1621. PMID: 37168651; PMCID: PMC10165504.

Cicconetti P, Di Berardino A, Cacciafesta M. Resistant hypertension in the elderly. Recenti Progressi in Medicina. 2017 Jul 1;108(7):316-23.

https://europepmc.org/article/med/28845853

Hering D, Mahfoud F, Walton AS, Krum H, Lambert GW, Lambert EA, Sobotka PA, Böhm M, Cremers B, Esler MD, Schlaich MP. Renal denervation in moderate to severe CKD. Journal of the American Society of Nephrology. 2012 Jul 1;23(7):1250-7.

Laurent S, Schlaich M, Esler M. New drugs, procedures, and devices for hypertension. The Lancet. 2012 Aug 11;380(9841):591-600.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60825-3/abstract?rss=yes=

Li HB, Lu Y, Zheng TZ. Rostral ventrolateral medulla and primary hypertension. Chin J Hypertens. 2011;19:917-9.

Victor RG. Carotid baroreflex activation therapy for resistant hypertension. Nature Reviews Cardiology. 2015 Aug;12(8):451-63.

https://www.nature.com/articles/nrcardio.2015.96

Zar T, Peixoto AJ. Paroxysmal hypertension due to baroreflex failure. Kidney international. 2008 Jul 1;74(1):126-31.

https://www.kidney-international.org/article/S0085-2538(15)53165-7/fulltext

Doucet BM, Lam A, Griffin L. Neuromuscular electrical stimulation for skeletal muscle function. The Yale journal of biology and medicine. 2012 Jun;85(2):201.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375668/

Mogili R, Kanala K, Challa BR, Chandu BR, Bannoth CK. Determination of rizatriptan in human plasma by liquid chromatography stable isotope dilution electrospray MS–MS for application in bioequivalence study. Chromatographia. 2011 Oct;74:585-92.

Johnson MI, Paley CA, Jones G, Mulvey MR, Wittkopf PG. Efficacy and safety of transcutaneous electrical nerve stimulation (TENS) for acute and chronic pain in adults: a systematic review and meta-analysis of 381 studies (the meta-TENS study). BMJ open. 2022 Feb 1;12(2):e051073.

Alahmari KA, Silvian P, Ahmad I, Reddy RS, Tedla JS, Kakaraparthi VN, Rengaramanujam K. Effectiveness of Low‐Frequency Stimulation in Proprioceptive Neuromuscular Facilitation Techniques for Post Ankle Sprain Balance and Proprioception in Adults: A Randomized Controlled Trial. BioMed Research International. 2020;2020(1):9012930.

Hering D, Trzebski A, Narkiewicz K. Recent advances in the pathophysiology of arterial hypertension: potential implications for clinical practice. Pol Arch Intern Med. 2017 Mar 1;127(3):195-204.

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Committee on Identifying Disabling Medical Conditions Likely to Improve with Treatment. Selected Health Conditions and Likelihood of Improvement with Treatment.

https://www.ncbi.nlm.nih.gov/books/NBK55951

Shimoji K, Takahashi N, Nishio Y, Koyanagi M, Aida S. Pain relief by transcutaneous electric nerve stimulation with bidirectional modulated sine waves in patients with chronic back pain: a randomized, double-blind, sham-controlled study. Neuromodulation: Technology at the Neural Interface. 2007 Jan 1;10(1):42-51.

Verville L, Hincapié CA, Southerst D, Yu H, Bussières A, Gross DP, Pereira P, Mior S, Tricco AC, Cedraschi C, Brunton G. Systematic review to inform a World Health Organization (WHO) clinical practice guideline: benefits and harms of transcutaneous electrical nerve stimulation (TENS) for chronic primary low back pain in adults. Journal of Occupational Rehabilitation. 2023 Dec;33(4):651-60.

Khadilkar A, Odebiyi DO, Brosseau L, Wells GA. Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low‐back pain. Cochrane Database of Systematic Reviews. 2008(4).

Chowdary KP, Chandra DU, Mahesh N, Reddy TM, Gopaiah KV. Enhancement of dissolution rate and formulation development of pioglitazone-a BCS class II drug. J. Pharm. Res. 2011 Nov;4:3862-3.

Herbert RD. How to estimate treatment effects from reports of clinical trials. I: Continuous outcomes. Australian Journal of Physiotherapy. 2000 Jan 1;46(3):229-35.

Wright A, Sluka KA. Nonpharmacological treatments for musculoskeletal pain. The Clinical journal of pain. 2001 Mar 1;17(1):33-46.

https://journals.lww.com/clinicalpain/fulltext/2001/03000/Chronic_Pain_in_the_Elderly__Occupational.6.aspx

Bharatia R, Kumar S, Chaursiya S, Gautam KM, Bharti S, Varun R. Sphingosomes: A Novel Vesicular Drug Delivery System. International Journal of Pharma Professional’s Research (IJPPR). 2023;14(3):88-93.

Myat A, Redwood SR, Qureshi AC, Spertus JA, Williams B. Resistant hypertension. BMJ. 2012 Nov 20;345:e7473. doi: 10.1136/bmj.e7473. PMID: 23169802.

https://pubmed.ncbi.nlm.nih.gov/23169802/